- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Percheron Therapeutics Ltd (PER)
Percheron Therapeutics Ltd stock price live, this page displays ASX PER stock exchange data. View the PER premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Percheron Therapeutics Ltd real time stock price chart below.
What Is the Percheron Therapeutics Ltd Stock Price Today?
The Percheron Therapeutics Ltd stock price today is 0.003.
What Is the Stock Symbol for Percheron Therapeutics Ltd?
The stock symbol for Percheron Therapeutics Ltd is "PER."
What Stock Exchange Does Percheron Therapeutics Ltd Trade On?
Percheron Therapeutics Ltd is listed and trades on the Sydney stock exchange.
Is Percheron Therapeutics Ltd a Good Stock to Buy?
Determining whether Percheron Therapeutics Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PER quote. (ISIN: AU0000317281)
What Is the Percheron Therapeutics Ltd Stock Price Today?
The Percheron Therapeutics Ltd stock price today is 0.003.
What Is the Stock Symbol for Percheron Therapeutics Ltd?
The stock symbol for Percheron Therapeutics Ltd is "PER."
What Stock Exchange Does Percheron Therapeutics Ltd Trade On?
Percheron Therapeutics Ltd is listed and trades on the Sydney stock exchange.
Is Percheron Therapeutics Ltd a Good Stock to Buy?
Determining whether Percheron Therapeutics Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PER quote. (ISIN: AU0000317281)
Sydney
Currency in AUD
0.003
-0.001(-25.00%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.003
0.003
52 wk Range
0.003
0.012
Trading near 52-week Low
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.0030.003
52 wk Range
0.0030.012
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
PER Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Impressive gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Neutral
Moving Averages
Buy
Earnings
Latest Release
Feb 26, 2026
EPS / Forecast
-- / -3.60
Revenue / Forecast
88.41K / --
Compare PER to Peers and Sector
Metrics to compare | PER | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPERPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.5x | −3.5x | −0.4x | |
PEG Ratio | −0.01 | 0.03 | 0.00 | |
Price/Book | 0.6x | 3.7x | 2.6x | |
Price / LTM Sales | 2.6x | 17.6x | 3.0x | |
Upside (Analyst Target) | - | 95.8% | 53.5% | |
Fair Value Upside | Unlock | 1.3% | 9.0% | Unlock |
Percheron Therapeutics Limited engages in the research and development of novel antisense pharmaceuticals for cancer and rare diseases in Australia. The company’s lead asset is ATL1102, an antisense oligonucleotide inhibitor of CD49d, which is in Phase IIb clinical trial for the treatment of Duchenne muscular dystrophy, multiple sclerosis, asthma, and other inflammatory indications. It also develops HMBD-002, a recombinant humanised monoclonal IgG4 antibody, which completed Phase I clinical trial to targer v-domain immunoglobulin suppressor of T-cell activation and cancer cells. The company was formerly known as Antisense Therapeutics Limited and changed its name to Percheron Therapeutics Limited in December 2023. Percheron Therapeutics Limited was incorporated in 2000 and is headquartered in Melbourne, Australia.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Percheron Therapeutics (PER) Stock Price Today?
The Percheron Therapeutics stock price today is 0.003 AUD.
What Stock Exchange Does Percheron Therapeutics Trade On?
Percheron Therapeutics is listed and trades on the Sydney Stock Exchange.
What Is the Stock Symbol for Percheron Therapeutics?
The stock symbol for Percheron Therapeutics is "PER."
What Is the Percheron Therapeutics Market Cap?
As of today, Percheron Therapeutics market cap is 4.570M AUD.
What Is Percheron Therapeutics's Earnings Per Share (TTM)?
The Percheron Therapeutics EPS (TTM) is -0.009.
From a Technical Analysis Perspective, Is PER a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Percheron Therapeutics Stock Split?
Percheron Therapeutics has split 4 times.
How Many Employees Does Percheron Therapeutics Have?
Percheron Therapeutics has 8 employees.
What is the current trading status of Percheron Therapeutics (PER)?
As of Jul 19, 2026, Percheron Therapeutics (PER) is trading at a price of 0.003 AUD, with a previous close of 0.004 AUD. The stock has fluctuated within a day range of 0.003 AUD to 0.003 AUD, while its 52-week range spans from 0.003 AUD to 0.012 AUD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.